Core Viewpoint - Option Care (OPCH) shares have increased by 10.1% in the past four weeks, closing at $29.69, with a mean price target of $39.13 indicating a potential upside of 31.8% according to Wall Street analysts [1] Price Targets and Analyst Consensus - The mean estimate consists of eight short-term price targets with a standard deviation of $2.64, where the lowest estimate of $36 suggests a 21.3% increase, and the highest estimate of $43 indicates a 44.8% surge [2] - A low standard deviation signifies strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [7] Earnings Estimates and Potential Upside - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [9] - Over the last 30 days, one estimate has increased, leading to a 0.7% rise in the Zacks Consensus Estimate for the current year [10] Zacks Rank and Investment Implications - OPCH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [11]

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies. Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they ...

Core Viewpoint - Option Care's recent earnings report shows a mixed trend in estimate revisions, leading to a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [2][7]. Financial Performance - Option Care reported quarterly earnings of $0.30 per share, exceeding the Zacks Consensus Estimate of $0.28 per share, but down from $0.63 per share a year ago [4]. - The company achieved revenues of $1.23 billion for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 4.79%, compared to $1.07 billion in the same quarter last year [10]. - The current consensus EPS estimate for the upcoming quarter is $0.31 on revenues of $1.2 billion, and for the current fiscal year, it is $1.19 on revenues of $4.76 billion [7]. Earnings Surprises and Trends - The quarterly report represented an earnings surprise of 7.14%, with the company having surpassed consensus EPS estimates in all four of the last quarters [5][9]. - Over the last four quarters, Option Care has consistently exceeded revenue estimates, achieving this four times [10]. Market Performance - Option Care shares have declined approximately 7% since the beginning of the year, contrasting with the S&P 500's gain of 14% [11]. - The company operates within the Medical - Outpatient and Home Healthcare industry, which is currently ranked in the bottom 39% of Zacks industries, indicating potential challenges ahead [15].

Core Insights - Option Care Health reported a net revenue of $1,227.2 million for Q2 2024, representing a 14.8% increase from $1,069.1 million in Q2 2023 [11] - The company experienced a net income of $53.0 million, or $0.30 diluted earnings per share, which is a 53.6% decrease compared to $114.4 million, or $0.63 diluted earnings per share, in the same quarter last year [11] - Adjusted EBITDA for Q2 2024 was $108.4 million, down 1.5% from $110.1 million in Q2 2023 [11] Financial Performance - Gross profit for Q2 2024 was $249.4 million, accounting for 20.3% of net revenue, slightly down from $250.8 million, or 23.5% of net revenue, in Q2 2023 [11] - Cash flow from operations increased to $195.7 million from $169.5 million in Q2 2023 [11] - The company repurchased approximately $78.1 million of stock during the quarter [11] Balance Sheet Highlights - Total assets as of June 30, 2024, were $3,348.6 million, up from $3,217.0 million at the end of 2023 [8] - Current assets increased to $1,227.4 million from $1,094.3 million at the end of 2023 [8] - Total liabilities rose to $1,937.2 million from $1,795.4 million at the end of 2023 [8] Guidance for Full Year 2024 - The company expects net revenue to be between $4.75 billion and $4.85 billion [23] - Adjusted EBITDA is projected to be between $435 million and $450 million [23] - Cash flow from operations is anticipated to be at least $300 million, consistent with previous guidance [23]

BANNOCKBURN, IL., July 31, 2024 - Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Note that the second quarter of 2023 net income and cash flow from operations includes $62.8 million related to the termination payment received on behalf of Amedisys, net of merger-related expenses and taxes. Conference Call OPTIO ...

Core Viewpoint - Option Care Health Inc. will release its second quarter results for the period ending June 30, 2024, on July 31, 2024, before market opening, followed by a conference call to discuss the results [2]. Group 1: Company Overview - Option Care Health is the largest independent provider of home and alternate site infusion services in the United States [4]. - The company employs over 7,500 team members, including more than 4,500 clinicians, and operates across all 50 states [4]. - Option Care Health aims to elevate standards of care for patients with acute and chronic conditions through clinical leadership and expertise [4]. Group 2: Conference Call Details - The conference call to review the second quarter results will take place at 8:30 a.m. E.T. on July 31, 2024 [2]. - Participants can pre-register for the conference call through a provided link and access a live audio webcast [3]. - A replay of the conference call will be available shortly after its completion and will remain accessible for approximately 90 days [3].

BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants ...

In the U.S. alone, national health expenditure is expected to increase annually from 2023 and 2032, according to the Centers for Medicare & Medicaid Services. So, profit is to be had in medicine — but only if you move fast enough. A Strong Buy rating from analysts Positive revenue and net income growth in its last annual report Trades above $10 Vericel (VCEL) Vericel (NASDAQ:VCEL) specializes in severe burns and sports medicines in the United States. The company has three main products: The company previous ...

Option Care (OPCH) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices - - has triggered this rating change. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Since a changing ...

BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: Webcast links and related presentation materials will be available online at https://investors.optioncarehealth.com. About Option Care Health Option Care Health is the nation's largest independent provider of home and alternate site in ...